Company Overview of Tosk, Inc.
Tosk, Inc., a biopharmaceutical company, discovers and develops new drugs that reduce or eliminate the adverse effects of existing pharmaceuticals while maintaining their efficacy. It improves the safety and efficacy of drugs for debilitating and life-threatening diseases, such as cancer, arthritis, and Crohn's disease. The company focuses on applying the optimizing marketed drugs technology to discover cancer chemotherapeutic side-effect-reducing agents for chemotherapeutics, methotrexate, and doxorubicin. Its drug discovery platform uses the common fruit fly (drosophila melanogaster) as a tool to discover new drugs. The company was founded in 1998 and is based in Santa Cruz, California.
2125 Delaware Avenue
Santa Cruz, CA 95060
Founded in 1998
Key Executives for Tosk, Inc.
Similar Private Companies By Industry
|DPT Laboratories, Ltd.||United States|
|Biological Mimetics, Inc.||United States|
|P3 Laboratories, LLC||United States|
|Kantata Pharmaceuticals||United States|
|Merck Sharp & Dohme Quimica de Puerto Rico, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Tosk, Inc., please visit www.tosk.com. Company data is provided by Capital IQ. Please use this form to report any data issues.